Immunotherapy And Chemotherapy Can Result In Long-Term Survival For Patients With Recurrent Or Progressive Non-Hodgkin'S Lymphoma After Reduced-Intensity Allogeneic Stem Cell Transplantation.
BLOOD(2004)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要